Globus Medical, Inc.
US ˙ NYSE ˙ US3795772082

SecurityGMED / Globus Medical, Inc.
InstitutionQuarry LP
Latest Disclosed Ownership1,640 shares
Latest Disclosed Value $ 141,302
Quarry LP reports 3,713.95% increase in ownership of GMED / Globus Medical, Inc.

On May 15, 2026 - Quarry LP filed a 13F-HR form disclosing ownership of 1,640 shares of Globus Medical, Inc. (US:GMED) valued at $141,302 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 43 shares of Globus Medical, Inc.. This represents a change in shares of 3,713.95% during the quarter. The current value of the position is $131,200 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GLOBUS MED CL A 379577208 1,640 1,597 3,713.95 141 4,600.00 0.0253
2026-02-13 2025-12-31 13F GLOBUS MED CL A 379577208 43 -20 -31.75 4 0.00 0.0006
2025-11-14 2025-09-30 13F GLOBUS MED CL A 379577208 63 -2,335 -97.37 4 -97.87 0.0008
2025-08-14 2025-06-30 13F GLOBUS MED CL A 379577208 2,398 2,398 142 0.0301
2025-05-15 2025-03-31 13F GLOBUS MED CL A 379577208 0 -1,453 -100.00 0 -100.00
2025-02-14 2024-12-31 13F GLOBUS MED CL A 379577208 1,453 958 193.54 120 242.86 0.0169
2024-11-14 2024-09-30 13F GLOBUS MED CL A 379577208 495 433 698.39 35 775.00 0.0089
2024-08-16 2024-06-30 13F/A-1 GLOBUS MED CL A 379577208 62 -902 -93.57 4 -92.16 0.0012
2024-08-14 2024-06-30 13F GLOBUS MED CL A 379577208 62 -902 4 0.0012
2024-05-15 2024-03-31 13F GLOBUS MED CL A 379577208 964 143 17.42 52 18.60 0.0099
2024-02-20 2023-12-31 13F/A-1 GLOBUS MED CL A 379577208 821 -475 -36.65 44 -32.81 0.0068
2024-02-14 2023-12-31 13F GLOBUS MED CL A 379577208 821 -475 44 0.0063
2023-11-14 2023-09-30 13F GLOBUS MED CL A 379577208 1,296 1,021 371.27 64 300.00 0.0150
2023-08-14 2023-06-30 13F GLOBUS MED CL A 379577208 275 -205 -42.71 16 -40.74 0.0053
2023-05-15 2023-03-31 13F GLOBUS MED CL A 379577208 480 480 27 0.0060
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.